4ª Edição

Mosunetuzumab induces complete remission in poor-prognosis non-Hodgkin’s lymphoma patients

per: Grupo Oncoclínicas
Mosunetuzumab induces complete remission in poor-prognosis non-Hodgkin’s lymphoma patients

Scientific commission

Carla Boquimpani
Carla Boquimpani
Evandro Fagundes
Evandro Fagundes
Jacques Tabacof
Jacques Tabacof
Rosa Arcuri Vasconcelos
Rosa Arcuri Vasconcelos

Contributors

Alexandre Barbosa Sotero Caio
Alexandre Barbosa Sotero Caio
Rosa Arcuri Vasconcelos
Rosa Arcuri Vasconcelos

This is a scientific newsletter curated by the main medical-scientific content for each specialty and interdisciplinary work between oncology and other areas. Enjoy your reading!

Access the full article of this study
Download
Share
Or share the link
Link copied to your desktop.L